BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 31227496)

  • 1. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
    Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
    Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline MBD4 Mutations and Predisposition to Uveal Melanoma.
    Derrien AC; Rodrigues M; Eeckhoutte A; Dayot S; Houy A; Mobuchon L; Gardrat S; Lequin D; Ballet S; Pierron G; Alsafadi S; Mariani O; El-Marjou A; Matet A; Colas C; Cassoux N; Stern MH
    J Natl Cancer Inst; 2021 Jan; 113(1):80-87. PubMed ID: 32239153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.
    Martin M; Maßhöfer L; Temming P; Rahmann S; Metz C; Bornfeld N; van de Nes J; Klein-Hitpass L; Hinnebusch AG; Horsthemke B; Lohmann DR; Zeschnigk M
    Nat Genet; 2013 Aug; 45(8):933-6. PubMed ID: 23793026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
    Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH
    Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
    Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
    Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.
    Lake SL; Damato BE; Kalirai H; Dodson AR; Taktak AF; Lloyd BH; Coupland SE
    Am J Pathol; 2013 Mar; 182(3):678-87. PubMed ID: 23357503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 10. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
    van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
    Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab.
    Johansson PA; Stark A; Palmer JM; Bigby K; Brooks K; Rolfe O; Pritchard AL; Whitehead K; Warrier S; Glasson W; Hayward NK
    Immunogenetics; 2019 May; 71(5-6):433-436. PubMed ID: 30714079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline loss-of-function variants in MBD4 are rare in Finnish patients with uveal melanoma.
    Repo P; Jäntti JE; Järvinen RS; Rantala ES; Täll M; Raivio V; Kivelä TT; Turunen JA
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):756-762. PubMed ID: 32421892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of monosomy 3 in uveal melanoma.
    Prescher G; Bornfeld N; Hirche H; Horsthemke B; Jöckel KH; Becher R
    Lancet; 1996 May; 347(9010):1222-5. PubMed ID: 8622452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
    Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients.
    Saint-Ghislain M; Derrien AC; Geoffrois L; Gastaud L; Lesimple T; Negrier S; Penel N; Kurtz JE; Le Corre Y; Dutriaux C; Gardrat S; Barnhill R; Matet A; Cassoux N; Houy A; Ramtohul T; Servois V; Mariani P; Piperno-Neumann S; Stern MH; Rodrigues M
    Eur J Cancer; 2022 Sep; 173():105-112. PubMed ID: 35863105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma.
    de Lange MJ; van Pelt SI; Versluis M; Jordanova ES; Kroes WG; Ruivenkamp C; van der Burg SH; Luyten GP; van Hall T; Jager MJ; van der Velden PA
    Oncotarget; 2015 Nov; 6(35):37824-35. PubMed ID: 26462151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MBD4 inactivation induces a new mutator phenotype in cancers].
    Rodrigues M; Mobuchon L; Houy A; Derrien AC; Stern MH
    Bull Cancer; 2018 Sep; 105(9):736-737. PubMed ID: 30032956
    [No Abstract]   [Full Text] [Related]  

  • 19. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.
    Rodrigues M; Mobuchon L; Houy A; Fiévet A; Gardrat S; Barnhill RL; Popova T; Servois V; Rampanou A; Mouton A; Dayot S; Raynal V; Galut M; Putterman M; Tick S; Cassoux N; Roman-Roman S; Bidard FC; Lantz O; Mariani P; Piperno-Neumann S; Stern MH
    Nat Commun; 2018 May; 9(1):1866. PubMed ID: 29760383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating uveal melanoma cytogenetics into clinical care.
    Damato B; Coupland SE
    Arch Ophthalmol; 2009 Apr; 127(4):423-9. PubMed ID: 19365018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.